NFKB1 and metabolic dysfunction-associated steatotic liver disease: Rutin could suppress hepatic lipid levels and oxidative injury to improve NAFLD in mice [52], ginsenoside Rg1 could effectively ameliorate hepatic steatosis and inflammation possibly via the AMPK/NF-kB pathway [53], and ginsenoside Rb1 alleviated high-fat diet-induced hepatocyte apoptosis in mice [54].